Originally, the correlation between FTO single-nucleotide polymorphisms or overweight and the likelihood of malignancy beginning was heavily focused on throat, mammary, prostate, renal, pancreas, and endometrium cancers [32]. The gene discussed is FTO; the disease is cervical carcinoma.